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1 Introduction
Through the introduction of high performance
liquid chromatography (HPLC) into the analytics
of phospholipids (PL) it has become possible to
detect the main PL in amniotic fluid quantitatively
and with high sensitivity. So HPLC has enabled
advances in fetal lung maturity determination as
one of the main problems in perinatology [1, 2,
3]. Nevertheless quantitation by HPLC is limited
due to the absence of a universal detector to meas-
ure molar quantities. UV detection is convenient
but has the disadvantage that carbon double
bounds of unsaturated PL produce higher UV-
signals than the carbonyl groups of the disaturated
dipalmitoyl lecithin as the main component of the
surfactant lecithin.
On the other hand HPLC detection systems like
fluorescence detection [7] or differential refracto-
metric (RI) detection [4] are very sophisticated and
the determinations are very time consuming be-
cause of post column derivatisation of the com-
pounds [7J. Identification of PL by mass detection
is even more expensive, time consuming and dif-
ficult to handle [9].
For clinical use these detection methods are no
alternatives for easy to handle UV-equipment, if
the influence of the unsaturated PL-compounds is
minimized by optimized column separation con-
ditions.
Publications of PISON et al. [6] and D'CosTA et al.
[2] validate the HPLC-UV-results by comparison
with thinlayer Chromatographie determination,
but the demonstrated HPLC chromatograms [2]
(figure 1) are unsatisfactory. So the first aim of
our work had to be the optimisation of the column
conditions.
Since phospholipids are not only to be found in
amniotic fluid they are of general interest. So it
seemed to be important to check the validity of
the method in other biological fluids like tracheal
secretion, gastric aspirate, lung lavages, human
milk, cow's milk and also in infant formulas.
Therefore the second aim of our work was to
extend the spectrum of application of our HPLC
method. The necessary improvements and modi-
fications can be summarized in two points:
a) Alteration of the extraction procedure to com-
plete the extraction of phosphatidylethanolamine
(PE) and phosphatidyHnositol (PI) in order to
make a second extraction superfluous. This second
extraction is very time consuming and cannot be
performed in media like milk and tracheal secre-
tion due to the presence of other ingredients, for
example, high fat contents.
b) Improvement of the layer separation, since there
is no separation of the extraction layers in am-
niotic fluid samples containing large amounts of
meconium.
2 Materials and methods
2.1 Standards and reagents
The following phospholipids listed were purchased
from SIGMA (Munich, FRG): phosphatidylgly-
cerol (PG) (ammonium salt, egg yolk), phospha-
tidyHnositol (PI) (ammonium salt, soybean) phos-
phatidylethanolamine (PE) (lecithin typ III, egg
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yolk), phosphatidylcholine (PC) (lecithin type III
E, egg yolk) sphingomyelin (SP) .(bovine brain)
and lysolecithin (LL) (type I, soybean). Acetonitril
(HPLC-grade) was obtained from PROMO-
CHEM (Hamburg-Wesel, FRG). We use chloro-
Figure 1. HPLC chromatogram of an amniotic fluid
sample with tracing of the mobile phase of acetonitrile-
water.
form and methanol in the pro analysi quality for
the extraction, and for the chromatography in the
Lichrosolv quality from MERCK (Darmstadt,
FRG). Furthermore aqua tridest is used.
2.2 Preparation of the samples
The clean up of amniotic fluid samples is different
from the other media in some points and will
therefore be described separately as follows:
2.2.1 Amniotic fluid
Amniotic fluid, either freshly withdrawn or stored
at -18 °C is centrifuged for 10 minutes at 700 g
(2500 rpm rotor radius 10 cm). 1,5 ml of the
supernatand is pipetted into a glass centrifuge tube
with cut and point and mixed with 30 g lysole-
cithin as internal standard. A LL solution is used
diluted with 2 g LL^g chloroform-methanol 2:1
(v/v).
2.2.2 Other media
Since phospholipids are widespread in biological
materials, it seemed very important to us to prove
the validity of the method in different media. Con-
sistency, viscosity, composition and concentrations
of the various media differ in a broad spectrum.
Therefore a comment should be made on the pre-
preparation of the samples and on the minimum
amounts. Later the samples are dealt with in ex-
actly the same way as amniotic fluid. However,
the amounts of the single PL components, as the
results given later will show, vary a lot.
Table I illustrates the 10 different media that have
already been examined for their phospholipid con-
tent. Among these there are also some media taken
Table I. Table of examples for using phospholipid determination in various media
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from animal material. The amounts can vary a lot
according to their PL concentration. In cases of
clear solutions only one previous centrifugation is
necessary. Slimy or turbid media need to be ho-
mogenized before being dealt with, to enable a
complete extraction. Alveolar lavages of the rat
and bronchial lavages of the human being can
show variable consistency — due to previous treat-
ment, kind of illness or premedication. Samples
may be clear, others can be extremely inhomoge-
neous. The latter must be homogenised in any case
before the extraction. The minimum amount of
amniotic fluid from rats should be 2 g if possible.4
However due to the small amount of amniotic
fluid in pregnant rats this is mostly not available;
even when the amniotic fluid samples of a mother
animal are pooled after cesarean section. The min-
imum of 0.5 g tracheal secretion of the newborn
refers to undiluted samples. If the newborn has
aspirated deeply, that is if the tracheal secretion is
strongly diluted with amniotic fluid, then a larger
amount of l g or more is necessary, due to the
smaller PL concentrations. 100 ml rinsing liquid
— normally physiologic saline solution — is used
for the alveolar lavages of rats and for the bron-
chial lavages of humans. Experience has shown
that only about 60 ml of the 100 ml solution used
can be recovered. 2 ml of this amount should be
dealt with at a time.
It should also be noted that LL cannot be used as
the internal standard for samples that already
contain lysolecithin. This is the case in some for-
mulas, for example "APONTI1" [5]. In such cases
the whole amount of the bottom layer and the
amount of the transferred aliquote have to be
determined for the calculation of the absolute con-
centrations after extraction. Instead of the normal
glass tubes graduated centrifuge tubes have to be
used. The evaluation in these cases was made
according to the 100% method (see chapter 2.4).
2.3 Extraction
3.25 ml chloroform, 2.75 ml methanol and 1.50
ml of the centrifugate to be examined were pipet-
ted into each tube. In serial runs the chloroform-
methanol mixture can be mixed in advance at a
ratio of 1.18:1 (for example, 325 ml chloroform
+ 275 ml methanol) in order to simplify the pro-
cedure. 6.0 ml of this solution are used for each
examination. The samples are sealed with a glass
stopper, shaken by hand for 5 minutes and are
deposited in an ice-bath for 5 minutes for better
separation of layers. Then the samples are centri-
fuged at 800 g (3000 rpm, rotor radius 10 cm) for
3 minutes. Afterwards the bottom layer is carefully
removed using a 5 ml disposable syringe with a
canula (0.9 χ 110 mm) and transfered into an-
other glass centrifuge pointed tube. One must take
care that no contamination from the upper layer
gets into the canula. This is done by carefully
pressing some air out of the syringe into the so-
lution when transferring the canula into the bot-
tom layer. The bottom layer pipetted in this way
is then evaporated by pure nitrogen to complete
dryness. In order to accelerate this procedure, the
samples are warmed up slightly in an air bath.
After cooling of the glass centrifuge tube with ice
for a short time, the residue is absorbed immedi-
ately in 100 μΐ chloroform-methanol (Lichrosolv)
at a ratio of 2:1 (v/v) before being injected into
the HPLC injection valve. 20 μΐ of this solution
are injected into the HPLC equipment at a time.
2.4 Chromatographie analysis
The phospholipids PG, PI, PE, PC, SP and LL
obtained from the chloroform layer of the extrac-
tion are separated using HPLC equipment sup-
plied by KNAUER (Berlin, FRG). The measuring
unit consists of:
two HPLC pumps, an HPLC programmer, a col-
umn oven and a variable wavelength detector.
Quantitation was carried out by integration of the
peak areas by a SHIMADZU C-R3A integrator. To
improve the quantitation of the chromatograms
we supplemented the apparatus by using a televi-
sion screen with an extra keyboard and floppy
disc for storing the chromatograms.
For separation we used a 25 cm χ 0.46 cm column
packed with 5 um Lichrosorb DIOL from MERCK
(Darmstadt, FRG), and a 6 cm χ 0.46 cm guard
column packed with 5 μπι Lichrosorb SI 60 and a
sample enriching content packed with 7 urn Lich-
rosorb SI 100, also from MERCK. The oven tem-
perature was 55 °C and the detection wavelength
was 201 nm. The mobile phase was composed of
solvent A: acetonitrile and solvent B: acetonitrile-
water 4:1, (v/v). The flow rate was constant at
2.5 ml/min. The following solvent gradient was
used: start with A = 88%, Β = 12%, from 5 until
7 minutes linear rise up to Β = 23%, from 8 to 11
minutes linear rise up to Β = 70%, from the be-
ginning to the end of the 12th minute a linear rise
up to Β = 75%. This mixture is kept on a constant
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level until the end of the 18th minute. The content
of B falls linearly to 12% during the 19th minute.
Figure 1 shows the tracing of the chromatogram
and the described gradient course of an amniotic
fluid sample taken in the 36th week of gestation.
Because the variable water content of the eluents
produces an unstable baseline, all the chromato-
grams had to be baseline corrected. A blank chro-
matogram is traced for this purpose and is sub-
tracted from the sample chromatogram by the
computer. Depending on the LL-content there are
two ways of quantitating the results:
a) automatic quantitation using the "internal stand-
ard method": we use LL as internal standard for
quantitative determination of the phospholipids.
This substance is particularly well suited for this
examination. It has a suitable retention time and
is normally below detection limit in the media
examined. Quantitation occurs automatically us-
ing computer calculation giving single concentra-
tions in mg/100 ml. The calibration curve was
achieved using a solution (chloroform-methanol
2:1) containing 2 μg of the phospholipids to be
examined.
b) manual quantitation following the "100%
method": samples that already contain LL are
extracted and measured without the addition of
LL as internal standard. In these cases the quan-
titation is done according to the 100% method.
The amounts of the single components are calcu-
lated through comparisons of the peaks of the
samples with those of a standard mixture.
3. Verification of the method
3.1 Linearity and detection limits
The linearity of the measuring signals has already
been proved in our earlier published examination
[3]. When examining the standard solution there
was a detection limit of 0.1 μg/100 ml in all of the
PL examined. In amniotic fluid the detection limits
are at about 0.2 μg/100 ml. However if other
biological materials like milk [5] or tracheal secre-
tions [8] are examined, containing a high fat level
or other interfering components, then the detec-
tion limits can even rise to above 0.3 μg/100 ml.
Quantitation problems can occur in these cases
due to superimposition particularly when deter-
mining PG on account of the enlargement of the
peaks appearing first on the chromatogram.
3.2 Recovery rates
3.2.1 Recovery rates in a standard mixture
To determine the recovery rates in a standard
mixture 15 μΐ of a PL standard solution, contain-
ing 15 μg of the phospholipids PG, PI, PE, PC,
SP and LL were diluted with aqua tridest to 1.5
ml and were prepared and analysed as described
in chapter 2.3 and 2.4. The results can be seen in
table II. The levels for PG, SP and LL lie very
close to the theoretical value of 100%. This proves
that LL is suitable as internal standard. In this
trial the values for PE and PC were somewhat too
high and the value for PI was clearly too low.

















































3.2.2 Recovery rates in a dilution run
To determine the recovery rates amniotic fluid
samples from the 40th week of gestation were
diluted in the ratio of 3:1, 1:1 respectively 1:3
(v/v) with samples of amniotic fluid from the 17th
week of gestation. In this way the recovery rates
can be checked under realistic and comparable
conditions. The contents of the phospholipids ex-
amined in the original amniotic fluid samples are
given in table III. In amniotic fluid from the 17th
week of gestation PG lies below the detection limit.
According to the fact that Pi-production is fore-
most accelerated during the 2nd trimenon of preg-
nancy, Pi-values are just above the detection limit.
Table IV shows the amounts measured in the cor-
responding mixtures in mg/100 ml. The recovery
rates are given in table V in percentage. The levels
fluctuate around the theoretical level of 100%.
Such fluctuations are justifiable in biological ma-
terial.
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3.3 Precision
3.3.1 Determination of the precision in a standard
solution
The precision of the series of runs and the preci-
sion from day to day in a standard solution of the
phospholipids was determined to provide further
statistical protection of the method. Table VI
Table ΙΠ. Phospholipid contents (x) with standard de-
viations (SD) and coefficients of variation (CV) of two
amniotic fluid samples (40th week of gestation and 17th
week of gestation) which are used for the dilution run





















































shows the results. When determining the precision
in the series 8 similar standard solutions are ex-
amined in one day. In this series 1 mg/100 ml
(corresponding to 15 μg substance per examina-
tion) is added to each of the PL to be examined.
The coefficient of variation (CV) fluctuates be-
tween 3.8% and 5.5% with a mean of 4.9%. When
determining the day to day precision, 5 samples
were examined over 6 days. The CV values fluc-




Determination of the precision in amniotic
Mature amniotic fluid from the 36th week of ges-
tation was examined to answer the question
whether the precision of the method also meets
the demands in this natural material. Table VII
shows the results of the precision in the series of
11 samples examined. Here the CV fluctuates be-
tween 1.8% and 5.3%, the mean is 3.1%.
Table IV. Phospholipid contents (x) with standard deviation (SD) and coefficients of variation (CV) of a dilution
run of the amniotic fluid samples described in table III
























































Table V. Recovery rates of a dilution run of the amniotic
fluid samples described in table III
PL N mixing ratio of AF (40 wks gest) :



































Table VI. Precision in series and day to day precision of
a phospholipid standard solution
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Table ΥΠ. Precision in series and day to day precision
of amniotic fluid samples (36th week of gestation)































































4 Results and discussion
The results demonstrate that by improving the
extraction procedure PE and PI can be quantita-
tively separated and so the second extraction step
can be saved. In this way we gain about 40 minutes
per analysis. This advantage is not offset by any
disadvantage since the measured detection limits,
the recovery rates and the precision both per day
and the precision from day to day are as good as
the results achieved in the method already de-
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Figure 2. HPLC chromatogram and computer point of a bronchial lavage of an adult.
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of the method and the base to base separation of
the PL components prove that there is no appre-
ciable interference of UV detection by unsaturated
PL-components. The time required for a single
analysis including blanks and measuring of the
standard solution amounts to about two hours.
When doing serial runs the time required is much
less, so that per day up to 12 samples can be
measured, and the time required per sample is
reduced to about 40 minutes. A further important
advantage of altering the method can be seen in
the fact that the quantitative determination of the
six mentioned phospholipids in other media than
amniotic fluid is only practicable at all when there
is no need for a second extraction. Without the
proposed changes — as could be shown in various
pretrials — the second extraction, according to
the pattern of the old method [3] could not be
performed at all in fatty media, such as milk and
tracheal secretion. Furthermore LL is a suitable
internal standard, since it is hardly ever present in
biological material. Only in those cases the some-
what more time-consuming and less accurate
100% method has to be used for the extraction
with exact determination of the sample volumes,
as described in chapter 2.4.
The chromatograms show sufficient separation of
the peaks in all the media examined. The quanti-
tation is of course difficult when certain compo-
nents like PG or SP are only available in small
quantities. Figure 2 shows the chromatogram of
a bronchial lavage of an adult with low content
of SP and a large amount of PC. Despite these
great differences in concentration it is still possible
in this case to get a sufficiently precise quantita-
tion. Another example of the use of this method
is given in the chromatogram of an infant formula
(APONTI PRE), shown in figure 3. This product
contains large amounts of PG. APONTI 1 on the
other hand contains small amounts of LL. We
have already reported on this result [5]. Further
examinations will have to be made to prove the




Figure3. HPLC chromatogram of an infant formula
(APONTI PRE).
In summarizing the results it can be said that the
HPLC method for determining the main phos-
pholipids described here is an improvement com-
pared to previous procedures and is able to detect
the main phospholipids specifically and quantita-
tively in other biological media recently with
standard HPLC equipment. Phospholipids carry
an important function in many spheres of medi-
cine. The improvement in specific, quantitative
methods for their determination is therefore of
great importance.
Abstract
A one step HPLC method for the determination of the
main phospholipids, phosphatidylglycerol (PG), phos-
phatidylinositol (PI), phosphatidylethanolamine (PE),
phosphatidylcholine (PC), sphingomyelin (SP) and ly-
solecithin (LL) in amniotic fluid, milk, tracheal secretion,
lung lavages, gastric aspirates, infant formulas and some
other human and animal media has been developed.
Quantitation occurs automatically using computer cal-
culation and lysolecithin as an internal standard. Detec-
tion limits are at about 0.2 μ§/100 ml but may rise to
about 0.3 μ§/100 ml in cases of high fat levels or other
interfering compounds. Recovery rates measured in am-
niotic fluid fluctuate around the 100% level.
Time required for a single analysing including a blank
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run and a calibration standard solution measurement
amounts to about two hours. In series analysis 12 sam-
ples per day can be examined, while the required time
per sample is reduced to 40 minutes.
As phospholipids carry an important function in many
spheres of medicine, the improvement in specific quan-
titative determination of these compounds is of great
importance.
Keywords: Amniotic fluid, fetal lung maturity, high performance liquid chromatography (HPLC), lung lavages,
milk, phospholipids, tracheal secretion.
Zusammenfassung
Vereinfachte quantitative Bestimmung von Phospholipiden
in Fruchtwasser, Alveolarlavagen und Milch mittels Hoch-
druckflüssigkeitschromatographie (HPLC)
Durch Einführung der Hochdruckflüssigkeitschroma-
tographie (HPLC) in die Analytik der Phospholipide
(PL) ist es möglich geworden, die Hauptphospholipide
im Fruchtwasser quantitativ und mit hoher Empfind-
lichkeit zu bestimmen. So konnten durch Einführung
der HPLC erhebliche Fortschritte bei der Bestimmung
der fetalen Lungenreife, die eines der Hauptprobleme
der Perinatologie darstellt, erreicht werden. Die Phos-
pholipide sind nicht nur im Fruchtwasser von Bedeu-
tung, sondern stellen ein biochemisches Problem von
allgemeinem Interesse dar. Daher schien es sinnvoll, die
Anwendbarkeit der HPLC-Methode auch für andere
biologische Medien wie Trachealsekret, Magensaft, Lun-
genlavagen, Mutter- und Kuhmilch sowie Säuglingsnah-
rungen zu überprüfen. Die hierzu notwendigen Verbes-
serungen und Veränderungen der Methode lassen sich
in zwei Punkten zusammenfassen:
1. Veränderung des Extraktionsverfahrens zur Verbes-
serung der Extraktion von Phosphatidyläthanolamin
(PE) und Phosphatidylinositol (PI), um eine zweite Ex-
traktion überflüssig zu machen. Diese zweite Extraktion
ist sehr zeitaufwendig und bei anderen Medien wie Milch
und Trachealsekret wegen der vielen weiteren Bestand-
teile nicht durchführbar.
2. Verbesserung der Phasentrennung, da es zum Beispiel
bei stark mekoniumhaltigen Fruchtwasserproben zu kei-
ner Trennung der Extraktionsphasen kommt.
Tabelle I zeigt in der Übersicht 10 verschiedene Medien,
die auf ihren Phospholipidgehalt bereits untersucht wur-
den. Darunter sind auch einige Medien, die aus tieri-
schem Material gewonnen wurden. Je nach Konzentra-
tion können die Einsatzmengen stark variieren. Bei kla-
ren Lösungen ist zur Vorbereitung nur das Zentrifugie-
ren notwendig. Wenn es sich um schleimige oder trübe
Medien handelt, muß dagegen vor der Aufarbeitung
homogenisiert werden, um eine vollständige Extraktion
zu ermöglichen. Die bei der Extraktion gewonnenen
Phospholipide, Phosphatidylglycerol (PG), Phosphati-
dylinositol (PI), Phosphatidyläthanolamin (PE), Phos-
phatidylcholin (PC), Sphingomyelin (SP) und Lysolezi-
thin (LL) werden mit einer HPLC-Anlage der Firma
KNAUER (Berlin) getrennt. Die quantitative Auswertung
erfolgt durch Integration der Peakflächen mittels eines
Integrators der Firma SHIMADZU C-R3A. Zur besseren
Auswertung der Chromatogramme haben wir die Anlage
durch ein Bildschirm-Sichtgerät mit Extratastatur und
Floppydisk zur Chromatogrammspeicherung ergänzt.
Da der unterschiedliche Wassergehalt der Eluenten einen
Anstieg der Grundlinie verursacht, müssen alle Chro-
matogramme basislinienkorrigiert werden. Abhängig
vom LL-Gehalt der Proben gibt es zwei Möglichkeiten
zur quantitativen Auswertung der Ergebnisse:
a) automatische Auswertung nach der „internen Stan-
dardmethode"
b) manuelle Auswertung nach der „100% Methode".
Im Fruchtwasser liegen die Nachweisgrenzen bei etwa
0,2 g/100 ml. Werden jedoch andere biologische Ma-
terialien wie etwa Milch mit sehr hohem Anteil an Fetten
oder anderen Fremdstoffen untersucht, so können in
ungünstigen Fällen die Nachweisgrenzen auf über 0,3
g/100 ml steigen. Die Ergebnisse zeigen, daß durch
Verbesserung des Extraktionsverfahrens PI und PE aus-
reichend quantitativ extrahiert werden und so der zweite
Extraktionsschritt eingespart werden kann. Dadurch
wird pro Analyse ein Zeitgewinn von etwa 40 Minuten
erreicht. Dieser Vorteil wird durch keine Nachteile er-
kauft, denn die gemessenen Nachweisgrenzen, Wieder-
findungsraten und die Präzision sowohl am Tage, als
auch die Präzision von Tag zu Tag sind genausogut wie
die Werte der bereits beschriebenen Methode [3]. Die
ausreichenden Werte für Präzision und Wiederfindung
und die Basislinientrennung der PL Komponenten be-
weisen, daß keine ins Gewicht fallende Störung der UV
Detektion durch ungesättigte Phospholipidkomponen-
ten erfolgt. Der Zeitaufwand für eine Einzelanalyse be-
trägt mit Leerkurve und Messung des Standardgemi-
sches etwa zwei Stunden. Bei Serienmessungen verkürzt
sich der Zeitaufwand erheblich, so daß pro Tag bis zu
12 Proben gemessen werden können, womit der Zeit-
aufwand pro Probe auf etwa 40 Minuten sinkt. Die
Chromatogramme zeigen bei allen untersuchten Medien
eine ausreichende Trennung der Peaks. Schwierig wird
die Auswertung dann, wenn bestimmte Komponenten,
wie PG oder SP nur in sehr geringen Mengen vorhanden
sind.
Abb. 2 zeigt das Chromatogramm einer Bronchiallavage
eines erwachsenen Menschen mit geringem Gehalt an
SP und hohem Gehalt an PC. Trotz der großen Kon-
zentrationsunterschiede ist auch in diesem Fall eine aus-
reichend genaue Auswertung möglich. Ein weiteres Bei-
spiel für die Anwendung der Methode zeigt Abb. 3 mit
der Darstellung des Chromatogramms einer Säuglings-
nahrung (APONTI PRE). Dieses Produkt enthält hohe
Mengen an PG.
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Die vorliegende HPLC-Methode zur Bestimmung der
Phospholipide stellt eine deutliche Verbesserung gegen-
über dem bisher bekannten Verfahren dar und ist in der
Lage auch in anderen biologischen Medien die Haupt-
phospholipide spezifisch und quantitativ nachzuweisen.
Da die Phospholipide in vielen Bereichen der belebten
Natur wichtige Funktionen innehaben, kommt der Ver-
besserung ihrer Analytik ein hoher Stellenwert zu.
Schlüsselwörter: Fruchtwasser, Hochdruckflüssigkeitschromatographie (HPLC), Lungenlavagen, Lungenreife,
Milch, Phospholipide, Trachealsekret.
Resume
Determination quantitative simpliffiee des phospholipides
dans le liquide amniotique, les produites de lavage alveo-
laires et le lait a l'aide de Chromatographie en phase liquide
a haute performance (HPLC)
II est devenu possible de detecter quantitativement les
phospholipides (PL) principaux dans la liquide amnio-
tique avec une sensibilite elevee par Pintroduction de la
Chromatographie en phase liquide ä haute performance
(HPLC) pour l'analyse des PL. C'est ainsi que l'HPLC
a permis des progres pour la determination de la ma-
turite pulmonaire foetale qui represente un des problemes
principaux en perinatologie.
Du fait qu'on ne trouve pas seulement les phospholipides
dans le liquide amniotique sur lequel plusieurs methodes
de determination par HPLC ont ete mises au point Us
sont d'un interet general. C'est pourquoi il semble im-
portant de faire le bilan de la validite des methodes par
HPLC dans d'autres liquides biologiques tels que les
produits de secretion tracheale, le liquide d'aspiration
gastrique, les produits de lavage pulmonaire, le lait hu-
main et le lait de vache ainsi que dans les laits pour
enfants. L'amelioration et les modifications necessaires
peuvent etre resumees en deux points.
a) modification des techniques d'extraction pour comple-
ter l'extraction de la phosphatidylethanolamine (PE) et
du phosphatidylinositol (PI) afin de rendre superflue une
deuxieme extraction. Cette seconde extraction prend
beaucoup de temps et ne peut etre realisee dans des
milieux tels que de lait et les produits de secretion tra-
cheale du fait de la presence d'autres substances telles
que celles ä haute teneur en graisse.
b) amelioration de la separation en couches du fait qu'il
n'y a pas de separation des couches d'extractions dans
les liquides amniotiques contenant beaucoup de meco-
nium.
Le tableau I illustre les 10 differents milieux dont on a
dejä etudie la teneur en phospholipides. Parmi ceux-ci,
certains milieux proviennent de materiels animaux. Les
quantites peuvent varier largement selon la concentra-
tion des PL. Dans les cas ou on dispose de solutions
nettes, une seule centrifugation preliminaire est neces-
saire. Les milieux visqueux necessitent une homogeni-
sation prealable pour que soit possible une extraction
complete.
Les phospholipides phosphatidylglycerol (PG), phos-
phatidylinositol (PI), phosphatidylethanolamine (PE),
phosphatidylcholine (PC), sphingomyeline (SP) et lyso-
lecithine (LL) obtenus par extraction sont separes a
l'aide du materiel ä HPLC fournis par KNAUER (Berlin,
RFA). La quantification est menee ä bien par integration
des aires des pics par un integrateur Shimadzu C-R 3A.
Pour ameliorer la quantification des chromatogrammes
nous ameliorons l'appareillage en nous servant d'un
ecran de television avec un clavier et des disquettes pour
stocker les chromatogrammes. Comme la teneur des
eluats en eau est variable provoque une ligne de base
instable, il faut corriger la ligne de base de tous les
chromatogrammes.
II y a deux modes de quantification des resultats quant
ä la teneur en LL:
a) quantification automatique en utilisant LL comme
Standard interne.
b) quantification manuelle en suivant la methode des
100% pour les echantillon contenant dejä LL.
Dans le liquide amniotique, les limites de detection sont
d'environ 0,2 g/100 ml. Toutefois, si etudie d'autres
materiels biologiques comme le lait ou les produits de
secretions tracheales qui contiennent des taux eleves de
graisse ou d'autres composants qui interferent, les limites
de detection peuvent alors s'elever au-dessus de 0,3 g/
100ml.
Les resultats demontrent qu'en ameliorant la technique
d'extraction, on peut separer quantitativement PE et PI
et ainsi eviter l'etape de la seconde extraction. Et par la,
le gain est de 40 minutes par analyse. Cet avantage n'est
pas contrebalance par quelque desavantage puisque les
limites de detection mesurees, les taux de recuperation
ainsi que la precision qu'elle soit quotidienne ou jour
apres jour sont aussi bons que les resultats obtenus par
les methodes dejä decrites [3]. La precision et la fiabilite
süffisantes de la methode et la separation base par base
des composants PL prouvent qu'il n'y a pas d'interfe-
rence appreciable de detection UV avec les composants
PL insatures. Le temps necessaire pour une seule analyse
comprenant la mise ä zero et la mesure des echantillons
standards represente environ 2 heures. Lorsqu'on effec-
tue des examens en serie le temps necessaire est nettement
moindre de teile sorte que peut mesurer chaque jour
jusqu'ä 12 echantillons et le temps necessaire par echan-
tillon se reduit ä environ 40 minutes.
Les chromatogrammes montrent une separation süffi-
sante des pics pour tous les milieux examines. La quan-
tification est de fait difficile lorsque certains composants
tels que PG ou SP n'existent qu'en faible quantite. La
figure 2 montre les chromatogrammes d'un lavage bron-
chique d'un nouveau-ne avec une faible teneur en SP et
de grandes quantites de PC. Malgre ces grandes diffe-
rences de concentration, il est encore possible dans ce
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cas d'obtenir une quantification suffisemment precise.
Un autre exemple de Putilisation de cette methode est
fourni par les chromatogrammes d'un lait pour bebe,
montre dans la figure 3. Ce produit contient de grandes
quantites de PG.
La methode proposee represente une amelioration en
comparaison des techniques precedentes et est capable
de detecter les phospholipides principaux tant specifi-
quement que quantativement dans d'autres milieux bio-
logiques, celä de facon recente avec un equipement stan-
dard HPLC. Comme les phospholipides supportent une
fonction importante dans de nombreuses spheres medi-
cales, Amelioration des methodes specifiques et quan-
titatives de dosage revet une grande importance.
Mots-cles: Chromatographie en phase liquide a haute performance (HPLC), lait, lavages pulmonaires, liquide
amniotique, maturite pulmonaire foetale, phospholipides, secretion tracheale.
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